Cadila Healthcare Ltd - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper cutting dated May 28, 2021 with regard to audited financial results of the Company for the quarter / year ended on March 31, 202128-05-2021
28-05-2021
Cadila: All in for COVID while keeping a tab on complex pharma
Cadila's stock has been primed by a series of potential rollouts to meet the COVID challenge28-05-2021
Earnings Call for Q4FY21 of Cadila Healthcare
Conference Call with Cadila Healthcare Management and Analysts on Q4FY21 Performance and Outlook. Listen to the full earnings transcript.27-05-2021
Zydus Cadila to seek emergency use approval for its COVID-19 vaccine in next 2 weeks
"We have capacity to produce 1 crore doses (10 million) per month. With partnerships with other manufacturers and debottlenecking and improving on yields at our own plant, we will be able to expand capacity to 2.5-3 crore (25-30 million doses) next 4-6 months," Sharvil Patel, Managing Director, Cadila Healthcare said.27-05-2021
CADILA HEALTHCARE LTD. - 532321 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance27-05-2021
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release with regard to the Audited Financial Results of the Company for the quarter/year ended on March 31, 202127-05-2021
CADILA HEALTHCARE LTD. - 532321 - Book Closure For AGM And Dividend
Book Closure for AGM and Dividend27-05-2021
CADILA HEALTHCARE LTD. - 532321 - Board recommend Final Dividend (AGM on August 11, 2021)
Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2021, inter alia, have recommended final dividend of Rs. 3.50/- (@ 350%) per equity share of Re. 1/- each, subject to approval of theshareholders at the ensuing Annual General Meeting scheduled to be held on August 11, 2021.27-05-2021
CADILA HEALTHCARE LTD. - 532321 - Audited Financial Results For The Year Ended March 31, 2021
Audited Financial Results for the year ended March 31, 202127-05-2021